Skip to main content

Table 1 Characteristics of mammalian DGK subtypes

From: Diacylglycerol kinase as a possible therapeutic target for neuronal diseases

 

MW(KDa)

Localization

Enzymatic property

Function/Phenotype of KO

References

α

80

thymus, spleen> > kidny, brain (oligodendrocytes)

Ca2+, PS dependent R59022 sensitive activated by PIP3, PI(3,4)P2

T cell anergy tumor invasion insulin release

[11, 25, 33–37]

β

90

brain(CP > hip, cortex, olf) > adrenal gland > small intestine

Ca2+, PS dependent activated by PI(4,5)P2

impairment of memory impairment of memory (mania-like) severe seizure

[12, 29–31, 38, 39]

γ

88

retina, brain(Cb, hip)> > other tissues

Ca2+, PS dependent R59022 sensitive

insulin release

[13, 38]

δ

130

skeletal muscle > testis, colon

Ca2+, PS independent

type II diabetes EGF signaling, seizure

[15, 24, 28, 40, 41]

η

130-140

testis > brain, lung, spleen > heart

Ca2+ insensitive

bipolar disorder (?), Ras-Raf-MEK signaling

[16, 42–45]

κ

142

testis > spleen, pracenta,

Ca2+ insensitive

hypospadias

[20, 24]

ϵ

64

retina,brain,testis > ovary> > skeletal muscle heart

Ca2 + independent selectively for arachidonoyl DG

seizure

[14, 46]

ζ

104

thymus > brain(Cb, hip, olf)> > skeltal muscle, heart, pancreas

Ca2 + insensitive Mg2+, PS dependent

T cell anergy, cell cycle control spine maintenamce

[17, 26, 27, 33, 35, 47, 48]

ι

130

retina > brain (hip, CP, cortex, Cb, Dg)

Ca2+ insensitive

Ras GRP, Rap 1 signaling

[19, 22, 49, 50]

θ

110

brain(Cb, hip)> > small intestine, liver etc.

Ca2+ insensitive

neurotransmitter release?

[18]

  1. Cb; cerebellum, CP: caudate putamen, Dg; dandate gyrus, hip; hippocampus, Olf; olfactory bulb.